Ethyl 8-(2,3,4-trimethoxyphenyl)-8-oxooctanoate, 97.0%, 1g

2,2-Diethoxy-1-phenylethanone, 95.0%, 1kg

2-Methyl-3-(3-(Tetrahydro-pyran-2-yloxy)phenyl)-1-propene, 97.0%, 2g

4-(2-Hydroxypropan-2-yl)furan-2-sulfonamide, 98%, 100mg

4-Acetyl-1-methylpyridin-2(1H)-one, 95.0%, 1g

5-METHOXY-1H-INDOLE-6-CARBOXYLIC ACID, 95%, 250mg

6a,7,8,9-Tetrahydro-2H-[1,4]dioxino[2',3':4,5]benzo[1,2-e]pyrrolo[2,1-b][1,3]oxazin-11(3H)-one, 95.0%, 250mg

6,11-dihydropyrido[3,2-c][1,5]benzodiazepin-5-one, 97%, 1g

3-Acetylpyridine, 98.0%, 500g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95%, 500mg

Single-channel microliter pipette Transferpette® S variable, 10 to 100 µl, D-100, 1 piece

(Z)-Hex-3-en-1-yl propionate, 95.0%, 25g

(S)-2-(3-Chlorophenyl)pyrrolidine hydrochloride, 95.0%, 100mg